Showing results (241-250 of 269) with videos related to
Sort By:
Pageof 27
The Journal of Biological Chemistry|April 19, 2011
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitorSofiya Micheva-Viteva, Yoshifumi Kobayashi, Leonard C Edelstein, et al.Nature Communications|February 11, 2022
In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cellsBonnie Huang, James D Phelan, Silvia Preite, et al.Physical Review Letters|July 20, 2019
Spin Stripe Order in a Square Planar Trilayer NickelateJunjie Zhang, D M Pajerowski, A S Botana, et al.The Journal of Experimental Medicine|November 25, 2020
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphomaRaud Razzaghi, Shreya Agarwal, Nikita Kotlov, et al.ACS Pharmacology & Translational Science|December 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) InhibitorsAna Corrionero, Xiaohu Zhang, Patricia Alfonso, et al.Science Advances|July 18, 2025
BLIMP1 negatively regulates IL-2 signaling in T cellsSuyasha Roy, Min Ren, Peng Li, et al.Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigensRyan M Young, Tianyi Wu, Roland Schmitz, et al.Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.Science Signaling|July 20, 2022
A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cellsKristoffer H Johansen, Dominic P Golec, Bonnie Huang, et al.Pageof 27